Suchergebnisse - "Cerda, Eira"

PubPharm (12)

1

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Rinella, M. | Lazarus, J. | Ratziu, V. | +151

2

Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America

enthalten in: Journal of viral hepatitis | 2023

von Mendizabal, M. | Thompson, M. | Gonzalez-Ballerga, E. | +40

3

Implementation of a re‐linkage to care strategy in patients with chronic hepatitis C who were lost to follow‐up in Latin America

enthalten in: Journal of Viral Hepatitis | 2023

von Mendizabal, M. | Thompson, M. | Gonzalez‐Ballerga, E. | +40

4

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

enthalten in: Journal of autoimmunity | 2022

von Efe, C. | Taşçılar, K. | Gerussi, A. | +42

5

Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Baiges, A. | Cerda, E. | Amicone, C. | +28

6

Predicting portal thrombosis in cirrhosis : A prospective study of clinical, ultrasonographic and hemostatic factors

enthalten in: Journal of hepatology | 2021

von Turon, F. | Driever, E. | Baiges, A. | +21

CommentIn: J Hepatol. 2022 Jan;76(1):224-225. - PMID 34461209

7

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis : PROMETEO study

enthalten in: Hepatology international | 2020

von Poo, J. | Torre, A. | Aguilar-Ramírez, J. | +15

8

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study

enthalten in: Hepatology international | 2020

von Poo, J. | Torre, A. | Aguilar-Ramírez, J. | +15

9

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study

enthalten in: Hepatology international | 2020

von Poo, J. | Torre, A. | Aguilar-Ramírez, J. | +15

10

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study

enthalten in: Hepatology international | 2020

von Poo, J. | Torre, A. | Aguilar-Ramírez, J. | +15